Resumen
Objective: To examine and identify the scope of research addressing health information requirements for gout patients using value chain analysis. Methods: Five electronic databases (PubMed, CINAHL, ERIC, PsycINFO, Embase, and Scopus) and grey literature (WorldCat) were searched in accordance with a published protocol. Only English language articles were included, with no limitations for date of publication. The findings of the 33 studies included for final analysis were subsequently divided into 6 groups according to the stages of the care delivery value chain their research most closely pertained to: screening/preventing (n = 2), diagnosing (n = 1), preparing (n = 7), intervening (n = 11), recovering/rehabilitating (n = 5), and monitoring/managing (n = 13). Results: The 33 studies focused on one or more of the following information phenotypes: 1) pathophysiology; 2) medical treatment; and 3) nonpharmaceutical interventions. Long term treatment adherence was a popular topic amongst studies that focused on gout patient education. Conclusion: Based on the identified studies, gout patients are being told what to do, but are not being adequately educated regarding why recommended interventions are important or how to accomplish them. Practice implications: This review provides a foundation to develop and evaluate personalized education materials using value chain analysis.
| Idioma original | English |
|---|---|
| Páginas (desde-hasta) | 30-43 |
| Número de páginas | 14 |
| Publicación | Patient Education and Counseling |
| Volumen | 105 |
| N.º | 1 |
| DOI | |
| Estado | Published - ene 2022 |
Nota bibliográfica
Publisher Copyright:© 2021 Elsevier B.V.
Financiación
The project described was partially supported by the NIH National Center for Advancing Translational Sciences through grant number UL1TR001998 . The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. The project described was partially supported by the NIH National Center for Advancing Translational Sciences through grant number UL1TR001998. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.
| Financiadores | Número del financiador |
|---|---|
| National Institutes of Health (NIH) | |
| National Center for Advancing Translational Sciences (NCATS) | UL1TR001998 |
ASJC Scopus subject areas
- General Medicine